Shai Gozani, MD, PhD, NeuroMetrix Chief Executive Officer, will be presenting at the conference. Dr. Gozani will provide an overview of NeuroMetrix and will provide an update on operational and strategic matters relating to the business.

About NeuroMetrix:

NeuroMetrix, Inc. is a medical device company advancing patient care through the development and marketing of innovative products used to diagnose and treat diseases of the nervous system, neurovascular disorders, and pain. To date, our focus has been on the diagnosis of neuropathies and neurovascular disorders. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders. The NC-stat® System, the Company's neuropathy diagnostic system, has been on the market since May 1999 and is used in over 5,500 physician's offices and clinics in the United States. Diabetic retinopathy is a common neurovascular complication of diabetes and the leading cause of blindness among working age adults. Through its acquisition of EyeTel Imaging, the The Company owns worldwide rights to the DigiScope, which is a retinopathy detection system designed for use by primary diabetes care physician offices and optometry clinics.